Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.

Jay Kincannon

Concepts (98)

Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Hair Diseases
2
2016
8
0.620
Why?
Lichen Sclerosus et Atrophicus
1
2012
7
0.420
Why?
Skin Diseases, Vesiculobullous
1
2012
8
0.420
Why?
Neck
1
2012
99
0.400
Why?
Dermatitis
2
2024
36
0.310
Why?
Dermatitis, Atopic
2
2024
39
0.290
Why?
Nevus, Epithelioid and Spindle Cell
1
2005
15
0.260
Why?
Lupus Erythematosus, Cutaneous
1
2024
2
0.230
Why?
Syphilis
1
2024
27
0.220
Why?
Medication Adherence
1
2024
130
0.210
Why?
Hyperoxaluria
1
2022
4
0.210
Why?
Hyperoxaluria, Primary
1
2022
3
0.210
Why?
Urolithiasis
1
2022
4
0.210
Why?
Skin Diseases, Genetic
1
2023
8
0.210
Why?
Dermatology
1
2024
52
0.210
Why?
Lupus Erythematosus, Systemic
1
2023
68
0.200
Why?
Eosinophilia
1
2023
36
0.200
Why?
Diagnosis, Differential
2
2016
1036
0.180
Why?
Kidney Failure, Chronic
1
2022
198
0.180
Why?
Dermatologic Surgical Procedures
1
2020
35
0.180
Why?
Skin Neoplasms
1
2005
487
0.170
Why?
Lasers, Solid-State
1
2020
32
0.170
Why?
Veins
1
2020
71
0.170
Why?
Erythrasma
1
1998
1
0.160
Why?
Child, Preschool
6
2020
3876
0.160
Why?
Protein Synthesis Inhibitors
1
1998
18
0.160
Why?
Vascular Malformations
1
2020
98
0.160
Why?
Erythema
2
2023
38
0.160
Why?
Clarithromycin
1
1998
38
0.150
Why?
Warts
2
2010
13
0.150
Why?
Patch Tests
1
1997
6
0.150
Why?
Dermatitis, Contact
1
1997
3
0.150
Why?
Antigens, Fungal
2
2010
23
0.140
Why?
Skin
1
2020
415
0.140
Why?
Hair
1
2016
29
0.130
Why?
Immunotherapy
2
2010
235
0.120
Why?
Humans
17
2024
49914
0.120
Why?
Female
10
2022
26571
0.110
Why?
Anti-Bacterial Agents
1
1998
742
0.100
Why?
Hemorrhage
1
2012
194
0.090
Why?
Biopsy
1
2012
591
0.090
Why?
Candida
1
2010
60
0.090
Why?
Adolescent
5
2020
6416
0.090
Why?
Child
5
2024
6844
0.080
Why?
Neprilysin
1
2008
14
0.080
Why?
Hamartoma Syndrome, Multiple
1
2008
15
0.080
Why?
Antigens, CD34
1
2008
65
0.080
Why?
Proto-Oncogene Proteins c-bcl-2
1
2008
126
0.070
Why?
Immunohistochemistry
2
2008
972
0.070
Why?
Upper Extremity
1
2005
43
0.060
Why?
Biopsy, Needle
1
2005
182
0.060
Why?
Young Adult
3
2022
4031
0.060
Why?
Dermatologic Agents
1
2004
10
0.060
Why?
Skin Diseases
2
2003
114
0.060
Why?
Tacrolimus
1
2004
57
0.060
Why?
Infant
2
2023
3573
0.050
Why?
Antigens, Viral
1
2003
43
0.050
Why?
Follow-Up Studies
2
2005
2175
0.050
Why?
Oxalates
1
2022
11
0.050
Why?
Immunosuppressive Agents
1
2004
226
0.050
Why?
Rare Diseases
1
2023
43
0.050
Why?
Caregivers
1
2024
212
0.050
Why?
Risk Assessment
1
2005
1255
0.050
Why?
Photography
1
2020
32
0.040
Why?
Single-Blind Method
1
2020
115
0.040
Why?
Eyelashes
1
1999
3
0.040
Why?
Adult
3
2022
13352
0.040
Why?
Lymphedema
1
1999
43
0.040
Why?
Corynebacterium
1
1998
1
0.040
Why?
Treatment Outcome
3
2020
5177
0.040
Why?
Prospective Studies
2
2020
2345
0.040
Why?
Injections, Intralesional
2
2010
31
0.040
Why?
Conjunctival Neoplasms
1
1997
6
0.040
Why?
Sebaceous Glands
1
1997
13
0.040
Why?
Eye Abnormalities
1
1997
24
0.040
Why?
Choristoma
1
1997
23
0.040
Why?
Facial Neoplasms
1
1997
22
0.030
Why?
Nevus, Pigmented
1
1997
34
0.030
Why?
Ectodermal Dysplasia
1
1996
6
0.030
Why?
Tooth Abnormalities
1
1996
12
0.030
Why?
Infant, Newborn
1
2023
2728
0.030
Why?
Retrospective Studies
2
2020
6123
0.030
Why?
Male
5
2020
25446
0.020
Why?
Immunity, Cellular
1
2010
69
0.020
Why?
Brain
1
1997
1310
0.020
Why?
Epidermal Cyst
1
2008
12
0.020
Why?
Hair Follicle
1
2008
33
0.020
Why?
Syndrome
2
1999
237
0.020
Why?
Mumps
1
2003
13
0.010
Why?
Candidiasis
1
2003
114
0.010
Why?
Severity of Illness Index
1
2003
953
0.010
Why?
Lacrimal Apparatus Diseases
1
1997
6
0.010
Why?
Optic Disk
1
1997
20
0.010
Why?
Dental Caries
1
1996
7
0.010
Why?
Pedigree
1
1996
125
0.010
Why?
Middle Aged
1
2010
12292
0.010
Why?
Alopecia
1
1996
37
0.010
Why?
Magnetic Resonance Imaging
1
1997
1525
0.010
Why?
Kincannon's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description